Centiva Capital’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $758K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $233K | Sell |
|
|||||
|
2024
Q3 | $528K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $230K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $203K | Buy |
|
|||||
|
2023
Q1 | $203K | Sell |
|
|||||
|
2022
Q4 | $2.39M | Sell |
|
|||||
|
2022
Q3 | $2.79M | Buy |
|
|||||
|
2022
Q2 | $2.5M | Buy |
|
|||||
|
2022
Q1 | $1.99M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.26M | Sell |
|
|||||
|
2021
Q2 | $3.1M | Sell |
|
|||||
|
2021
Q1 | $3.13M | Buy |
|
|||||
|
2020
Q4 | $2.66M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $203K | Buy |
|